title: A unique mechanism for innate cytokine promotion of T cell responses to viral infections.
abstract: The kinetics of CD8 T cell IFN-gamma responses as they occur in situ are defined here during lymphocytic choriomeningitis virus (LCMV) infections, and a unique mechanism for the innate cytokines IFN-alphabeta and IL-18 in promoting these responses is defined. Infections of mice with Armstrong or WE strains of LCMV induced an unexpectedly early day 4 IFN-gamma response detectable in serum samples and spleen and liver homogenates. Production of IFN-gamma was MHC class I/CD8 dependent, but did not require IL-12, NK cells, TCR-gammadelta T cells, MHC class II, or CD4 T cells. Peak response required specific Ag recognition, as administration of antagonist peptide partially impaired day 4 IFN-gamma induction, and viral peptide stimulation enhanced CD8 T cell IFN-gamma expression in culture. The IFN-gamma response was associated with IL-18 and IFN-alphabeta expression. Furthermore, both factors augmented peptide-driven IFN-gamma production in culture, and mice lacking IL-18 or IFN-alphabeta functions had reduced day 4 IFN-gamma. Collectively, these results demonstrate that during viral infections, there is a dramatic in vivo CD8 T cell response preceding maximal expansion of these cells, and that the mechanism supporting this response is dependent on endogenous innate cytokines. Because stimulation by microbial products is linked to innate cytokine expression, the studies also suggest a pathway for precisely limiting T cell functions to times of need.
authors.affiliation: Department of Molecular Microbiology and Immunology, Division of Biology and Medicine, Brown University, Providence, RI 02912, USA.
authors.forename: Gary C
authors.initials: GC
authors.lastname: Pien
authors.forename: Khuong B
authors.initials: KB
authors.lastname: Nguyen
authors.forename: Lene
authors.initials: L
authors.lastname: Malmgaard
authors.forename: Abhay R
authors.initials: AR
authors.lastname: Satoskar
authors.forename: Christine A
authors.initials: CA
authors.lastname: Biron
mesh_terms: D000818:Animals; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology* / Q000378:metabolism* / Q000821:virology; D002478:Cells, Cultured; D016207:Cytokines / Q000502:physiology*; D004527:Egg Proteins / Q000502:physiology; D007113:Immunity, Innate / Q000235:genetics; D016056:Immunodominant Epitopes / Q000502:physiology; D007371:Interferon-gamma / Q000096:biosynthesis; D018664:Interleukin-12 / Q000502:physiology; D020382:Interleukin-18 / Q000502:physiology; D007700:Kinetics; D008213:Lymphocyte Activation / Q000235:genetics; D008216:Lymphocytic Choriomeningitis / Q000235:genetics / Q000276:immunology*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D009698:Nucleoproteins / Q000276:immunology / Q000502:physiology; D010047:Ovalbumin / Q000502:physiology; D010446:Peptide Fragments / Q000276:immunology / Q000502:physiology; D015398:Signal Transduction / Q000235:genetics / Q000276:immunology; D013997:Time Factors
chemical_list: D016207:Cytokines; D004527:Egg Proteins; D016056:Immunodominant Epitopes; D020382:Interleukin-18; D009698:Nucleoproteins; C110366:OVA-8; D010446:Peptide Fragments; D018664:Interleukin-12; D007371:Interferon-gamma; D010047:Ovalbumin